Anti-PLVAP monoclonal antibody

Pre-made anti-PLVAP monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PLVAP/PLVAP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1416-Ab-1/ GM-Tg-hg-IP1416-Ab-2Anti-Human PLVAP monoclonal antibodyHuman
GM-Tg-rg-IP1416-Ab-1/ GM-Tg-rg-IP1416-Ab-2Anti-Rat PLVAP monoclonal antibodyRat
GM-Tg-mg-IP1416-Ab-1/ GM-Tg-mg-IP1416-Ab-2Anti-Mouse PLVAP monoclonal antibodyMouse
GM-Tg-cynog-IP1416-Ab-1/ GM-Tg-cynog-IP1416-Ab-2Anti-Cynomolgus/ Rhesus macaque PLVAP monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1416-Ab-1/ GM-Tg-felg-IP1416-Ab-2Anti-Feline PLVAP monoclonal antibodyFeline
GM-Tg-cang-IP1416-Ab-1/ GM-Tg-cang-IP1416-Ab-2Anti-Canine PLVAP monoclonal antibodyCanine
GM-Tg-bovg-IP1416-Ab-1/ GM-Tg-bovg-IP1416-Ab-2Anti-Bovine PLVAP monoclonal antibodyBovine
GM-Tg-equg-IP1416-Ab-1/ GM-Tg-equg-IP1416-Ab-2Anti-Equine PLVAP monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1416-Ab-1/ GM-Tg-hg-IP1416-Ab-2; GM-Tg-rg-IP1416-Ab-1/ GM-Tg-rg-IP1416-Ab-2;
GM-Tg-mg-IP1416-Ab-1/ GM-Tg-mg-IP1416-Ab-2; GM-Tg-cynog-IP1416-Ab-1/ GM-Tg-cynog-IP1416-Ab-2;
GM-Tg-felg-IP1416-Ab-1/ GM-Tg-felg-IP1416-Ab-2; GM-Tg-cang-IP1416-Ab-1/ GM-Tg-cang-IP1416-Ab-2;
GM-Tg-bovg-IP1416-Ab-1/ GM-Tg-bovg-IP1416-Ab-2; GM-Tg-equg-IP1416-Ab-1/ GM-Tg-equg-IP1416-Ab-2
Products NameAnti-PLVAP monoclonal antibody
Formatmab
Target NamePLVAP
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PLVAP monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1416-Ag-1Recombinant multi-species PLVAP/ FELS/ PV-1 protein
    ORF Viral VectorpGMLPm003517mouse Plvap Lentivirus plasmid
    ORF Viral VectorvGMLPm003517mouse Plvap Lentivirus particle


    Target information

    Target IDGM-IP1416
    Target NamePLVAP
    Gene ID83483,84094,56765,719830,484837,101083067,524990,100147156
    Gene Symbol and SynonymsDIAR10,FELS,gp68,MECA32,PLVAP,PV-1,PV1
    Uniprot AccessionQ9BX97,Q9WV78
    Uniprot Entry NamePLVAP_HUMAN,PLVAP_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130300
    Target ClassificationN/A

    The target: PLVAP, gene name: PLVAP, also named as FELS, PV-1, PV1, gp68. Predicted to enable identical protein binding activity. Involved in MAPK cascade; positive regulation of cellular extravasation; and tumor necrosis factor-mediated signaling pathway. Located in cell surface. Colocalizes with caveola. Implicated in congenital diarrhea. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.